Shares of Sema4 Holdings Corp, a genetic-testing and health-data analytics business spun out of the Mount Sinai Health System, are set to start trading Friday after the business combined with a blank-check company backed by Casdin Capital and Corvex Management.
Investors in the special-purpose acquisition company, CM Life Sciences Inc., agreed to a deal that values the company at about $3bn, a spokeswoman said. Backers of the Stamford, Conn.-based business include Blackstone Group Inc. and Deerfield Management.
Subscribe to our Newsletter to increase your edge. Don’t worry about the news anymore, through our newsletter you’ll receive weekly access to what is happening. Join 120,000 other PE professionals today.
Blackstone is one of the world’s leading investment firms seeking to create positive economic impact and long-term value for investors. The firm has $649bn in assets under management include investment vehicles focused on private equity, real estate, public debt and equity, life sciences, growth equity, opportunistic, non-investment grade credit, real assets, and secondary funds, all on a global basis.
Source: Wall Street Journal
Can’t stop reading? Read more
TPG explores $7.5bn Asia OneHealthcare exit with sale or IPO options
TPG explores $7.5bn Asia OneHealthcare exit with sale or IPO options TPG has appointed Malayan...
Blackstone teams with Dubai Aerospace on $1.6bn annual aircraft leasing push
Blackstone teams with Dubai Aerospace on $1.6bn annual aircraft leasing push Blackstone has...
CVC seeks co-investors for $12.7bn Recordati buyout in mega LBO push
CVC seeks co-investors for $12.7bn Recordati buyout in mega LBO push CVC Capital Partners is...